Page 1,949«..1020..1,9481,9491,9501,951..1,9601,970..»

Reason to Bree-Lieve: Greenville girl continues to beat the odds

Posted: November 5, 2014 at 2:55 am

GREENVILLE, Mich., Looking at Bree Town these days, its hard to believe how far shes come in just a year.

Last November, the 11-year-old received the devastating news that her acute myeloid leukemia (AML) had returned and that she needed a bone marrow transplant to survive. After hundreds turned out for community bone marrow drives around West Michigan, Bree and her family learned the perfect match had been found overseas.

Her donor, an unidentified man in his early 20s from Germany, was able to provide lifesaving stem cells to the Baldwin Heights fifth grader.

Just weeks after receiving the transplant, Bree was able to return home in March. Against doctors expectations, she was also able to return to school at the beginning of the year.

Watch the video above to see what Bree is up to now and what she thinks about possibly meeting her donor one day.

FOX 17 first introduced you to Bree in June 2012 as she worked to pay it forward to other kids at DeVos Childrens Hospital in Grand Rapids, despite being diagnosed with AML. She captured the hearts of many in West Michigan and around the world who follow her progress on Facebook.

To learn more, visit her We Bree-Lieve page here.

Follow this link:
Reason to Bree-Lieve: Greenville girl continues to beat the odds

Posted in Michigan Stem Cells | Comments Off on Reason to Bree-Lieve: Greenville girl continues to beat the odds

MD Stem Cells Begins the Largest Stem Cell Eye Treatment …

Posted: November 5, 2014 at 2:55 am

RIDGEFIELD, Conn., Sept. 10, 2013 /PRNewswire/ --For patients with serious eye disease, going blind is a constant fear. The loss of vision experienced from retinal or optic nerve problems may be progressive with devastating impact on a person's ability to live a full life. Treatment with Bone Marrow DerivedStem Cellsmay hold the key to reversing blindness and restoring vision. But the concern has been whether such stem cell treatments have enough published reports and studies to show effectiveness in a convincing way.MD Stem Cellshopes to help provide that evidence.

MD Stem Cells is Collaborator for the new Stem Cell Ophthalmology Treatment Study, abbreviated asSCOTS. Dr. Steven Levy, President of MD Stem Cells, will function as Study Director for the clinical trial expected to continue through August 2017. The Retinal Associates of South Florida is the study Sponsor and Dr. Jeffrey Weiss, retinal surgeon and physician, is the Principle Investigator and provider of the ophthalmic stem cell treatments.

"We are extremely pleased to have helped design and implement this broadly encompassing retinal and optic nerve disease study," Dr. Levy exclaimed. "We believe ours is the largest, most comprehensive registered ophthalmology stem cell study to date. We have taken great care in powering the study and expect to obtain statistically meaningful results. SCOTS is being conducted under an Institutional Review Board whose evaluation was rigorous."

SCOTS is registered with the National Institutes of Health and listed on their website http://www.clinicaltrials.govwith identifierNCT01920867. Patients interested in whether they may participate and healthcare providers may reach Dr. Levy at info@mdstemcells.com or 203-423-9494 Eastern Time USA.

"We hope that the treatment will be shown to improve vision in the vast majority of individuals who are enrolled in SCOTS. Patients considering treatment should understand that this is clinical research and individual responses cannot be predicted," stated Dr. Levy. He added, "Our previous anecdotal experience with eye disease treated with stem cells has been positive. With SCOTS we hope to provide strong evidence of the effectiveness of these treatments to the medical community."

SOURCE MD Stem Cells

RELATED LINKS http://www.mdstemcells.com

See the original post:
MD Stem Cells Begins the Largest Stem Cell Eye Treatment ...

Posted in Maryland Stem Cells | Comments Off on MD Stem Cells Begins the Largest Stem Cell Eye Treatment …

Biotech company set to begin 3-D printing human tissue

Posted: November 5, 2014 at 2:52 am

California-based biotech firm Organovo is set to begin selling 3-D-printed liver tissue by the end of the year, part of the growing movement to bring the technology to the medical field. Credit: Courtesy of Organovo

NEW YORK (CNNMoney) Add one more to the growing list of 3-D-printed products: human organs.

California-based biotech firm Organovo is set to begin selling 3-D-printed liver tissue by the end of the year, part of the growing movement to bring the technology to the medical field.

Organovo cant yet print a fully functioning liver. But the company has already been working with a handful of laboratories to manufacture live liver tissue, offering scientists a new way to conduct research.

This gives researchers the kind of tool that they just havent head in the past, said Michael Renard, executive vice president at Organovo. They cant do the kind of experiments on a person that they can do with this tissue in a lab setting.

Within the next few years, Renard says 3-D-printed tissues could also be used in patient treatment, to replace small parts or organs or encourage cell regeneration.

So how do you print human tissue?

The process starts when scientists grow human cells from biopsies or stem cells. They then feed the cells into special printers that can arrange them three-dimensionally by cell type in the way that theyd appear in the human body.

Once the cells have been printed in the right arrangement, they begin to signal to one another, fuse and organize themselves into a collective system.

Renard didnt want to speculate on when the printing of whole organs might become a reality, but many researchers are excited about the possibility and its implications for transplant procedures.

Follow this link:
Biotech company set to begin 3-D printing human tissue

Posted in California Stem Cells | Comments Off on Biotech company set to begin 3-D printing human tissue

International Stem Cell Corp. Gets FDA Clearance

Posted: November 5, 2014 at 2:43 am

International Stem Cell Corp., a Carlsbad-based biotech company developing stem cell therapies and biomedical products, announced that the U. S. Food and Drug Administration has cleared the companys human parthenogenetic stem cell line for investigational clinical use.

Human embryonic stem cells typically come from fertilized eggs. In 2007, however, scientists at International Stem Cell Corp. (ISCO) reported the first successful creation of human stem cell lines from unfertilized eggs, according to Scientific American. They used a process called parthenogenesis, in which researchers use chemicals to induce the egg to begin developing as if it had been fertilized. The egg called a parthenote behaves just like an embryo in the early stages of division. Because it contains no genetic material from a father, however, it cannot develop into a viable fetus. Just like embryonic stem cells, parthenogenetic stem cells can be coaxed to grow into different kinds of human cells or tissue, ready to be transplanted into diseased areas of the body.

"Many stem cell lines can never be used to develop commercial therapeutic products because they don't meet the FDA's ethical and quality standards, said Ruslan Semechkin, ISCOs chief scientific officer. With this clearance from the FDA, based on the safety of our cells and quality of our manufacturing processes, the company has removed any uncertainty in the potential clinical use of human parthenogenetic stem cells. Not only does this increase the chance that our regulatory submission for the treatment of Parkinson's disease, which we will be submitting before the end of the year, will be approved, but it also means that our human parthenogenetic stem cells can serve as the basis for investigational clinical studies for other indications, for example stroke or traumatic brain injury."

To be approved by the FDA for use in human trials and commercial therapeutic products, stem cells must be grown under what's known as good manufacturing practice (GMP) conditions. GMP standards require that each batch of cells is grown in identical, repeatable conditions, ensuring that they have the same properties, and each person receiving a stem cell therapy would be getting an equivalent treatment. According to ISCO, achieving this level of consistency is difficult and requires knowing the exact identity and quantity of every component of the media that the cells grow in and characterizing cell batches extremely precisely, as well as rigorous quality control and assurance.

ISCO (OTCQB: ISCO) will use its own GMP facilities in Oceanside to produce the cells in preparation for the first clinical trial.

More here:
International Stem Cell Corp. Gets FDA Clearance

Posted in Stem Cell Therapy | Comments Off on International Stem Cell Corp. Gets FDA Clearance

Global Stem Cells Group Named Exclusive Distributor for Adistem and Adilyfe Companies and Product Lines

Posted: November 4, 2014 at 10:49 pm

MIAMI (PRWEB) November 04, 2014

Global Stem Cells Group, Inc. has been named exclusive distributor for Adistem medical solutions, and Adilyfe, a new regenerative medicine products company founded by Adistem Ltd. Scientific Founder Vasilis Paspaliaris, M.D. in Melbourne, Australia and set to launch in early 2015. Paspaliaris made the announcement at the First International Symposium on Stem Cells and Regenerative Medicine held in Buenos Aires, Argentina Oct. 2-4 and hosted by Global Stem Cells Group.

Adistem-Adilyfe will manufacture a group of products for use in stem cell treatments, therapies and training through the Adimarket Division of the Global Stem Cells Group. The timing is perfect for GSCGs current expansion into Latin American countries including Colombia, Costa Rica, Chile, Mexico and Peru, according to Global Stem Cells Group CEO Benito Novas.

Vasilis, an accomplished biotech scientist, stem cell researcher and pharmaceutical consultant joined the Global Stem Cells Group Scientific Advisory Board, part of the Regenestem Network.

As always, Dr. Paspaliaris brings excellence to stem cell research, Novas says. His work has already proven critical to improving the quality of life for a range of chronically ill patients all over the world.

We are honored to be representing Adistem and AdiLyfe products in Latin America; we consider the opportunity a strategic commitment to world class stem cell research.

Vasilis says he knew Global Stem Cells Group would be the only choice to represent Adistem and AdiLyfe in Latin America.

We are proud of our relationship with Global Stem Cells Group, we couldnt ask for better partners, Vasilis says.

To learn more about the Global Stem Cells Group, visit the website at http://www.stemcellsgroup.com, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.

About Global Stem Cell Group:

See the original post:
Global Stem Cells Group Named Exclusive Distributor for Adistem and Adilyfe Companies and Product Lines

Posted in Cell Medicine | Comments Off on Global Stem Cells Group Named Exclusive Distributor for Adistem and Adilyfe Companies and Product Lines

Fix You with Stem Cells – Video

Posted: November 4, 2014 at 9:48 pm


Fix You with Stem Cells
Description.

By: Oliver Sinclair

View post:
Fix You with Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on Fix You with Stem Cells – Video

Breast milk stem cells may be incorporated into baby

Posted: November 4, 2014 at 4:49 am

Breast milk is known for being full of goodies but could that include stem cells from mum that go on to transform into parts of the baby's body? Preliminary evidence has shown this happens in mice, suggesting it also does in people.

Stem cells have the unusual ability to regenerate themselves and develop into a variety of tissues. Several sources of stem cells are being developed for therapeutic use, including embryos, umbilical-cord blood and adult tissues.

It was discovered seven years ago that human breast milk also contains a kind of stem cell. The question was whether these cells do anything useful for the baby or if they simply leak unavoidably into breast milk.

The latest findings, presented at the National Breastfeeding and Lactation Symposium in London last week, suggest that in mice at least, breast milk stem cells cross into the offspring's blood from their stomach and play a functional role later in life.

Foteini Hassiotou at the University of Western Australia and her colleagues showed this by first creating genetically modified mice whose cells contain a gene called tdTomato, which makes them glow red under fluorescent light.

The females mice were mated but then after giving birth were given unmodified baby mice to suckle. So any red cells that ended up in the pups must have come via the milk.

Sure enough, when the offspring reached adulthood, red cells were found in their blood and many of their tissues, including the brain, thymus, pancreas, liver, spleen and kidneys. Using other techniques, Hassiotou's team also found that the stem cells had developed into mature cells. The ones in the brain, for instance, had the characteristic shape of neurons; the ones in the liver were making the liver protein albumin, and the ones in the pancreas were making insulin. "They seem to integrate and become functional cells," she says.

Is it simply that these stem cells play a role in normal growth and development, or might they also be, say, helping to make the offspring tolerant to its mother's cells and proteins, to reduce chances of an allergic reaction to her breast milk? "There must be some evolutionary advantage," says Hassiotou.

The finding that breast milk stem cells are capable of making different tissues makes it more likely they could be used for therapeutic applications, says Hassiotou. Chris Mason of University College London adds: "If these intriguing cells are functional, they could be a novel option for producing future cell therapies."

Breast milk stem cells seem to have less capacity for unlimited cell division than embryonic stem cells. "But that's actually a good thing," says Hassiotou. They do not form tumours when injected into mice, for example, so they may be less likely to trigger cancer if used to treat people.

Read more from the original source:
Breast milk stem cells may be incorporated into baby

Posted in Stem Cells | Comments Off on Breast milk stem cells may be incorporated into baby

Sugar-rich fat maintains supply of brain stem cells

Posted: November 4, 2014 at 4:49 am

New York, Nov 4 (IANS): Fat and sugar are considered to be the culprits when it comes to obesity and related health complications but if researchers are to be believed, a biological fat with a sugar attached to it is essential for maintaining the brain's supply of stem cells.

In lab experiments, the team discovered that in mice missing the sugar containing "lipid ganglioside GD3", neural stem cells have a dramatically impaired ability to self-renew.

"If GD3 is missing, we found these neural stem cells cannot be maintained throughout life. They are reduced by a big percentage even in a one-month-old mouse," said Jing Wang, postdoctoral fellow at the Medical College of Georgia from the Georgia Regents University in the US.

"In fact, by one month of life, there was about a 60 percent reduction in the supply and by six months, which is considered aged in a mouse, there were only a handful of neural stem cells remaining," Wang added.

Neural stem cells help the brain develop initially, then re-populate brain cells lost to usual cell death as well as to trauma, head injury or stroke.

GD3 plays an important role in growth factor signalling which, in turn, tells neural stem cells to proliferate or die.

Wang and colleague Robert K. Yu are optimistic that one day, manipulating levels of growth factors and sugar-containing lipids would enable a more steadfast supply of neural stem cells throughout life.

The study appeared in the Journal of Neuroscience.

Stay updated wherever you go with Daijiworld.com and Daijiworld 24X7 tv channel mobile apps. CLICK HERE to download it for your device. (available on Android and IOS)

See the original post:
Sugar-rich fat maintains supply of brain stem cells

Posted in Stem Cells | Comments Off on Sugar-rich fat maintains supply of brain stem cells

NSAIDs prevent colon cancer by inducing death of intestinal stem cells that have mutation

Posted: November 4, 2014 at 4:49 am

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against the development of colorectal cancer by inducing cell suicide pathways in intestinal stem cells that carry a certain mutated and dysfunctional gene, according to a new study led by researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine. The findings were published online in the Proceedings of the National Academy of Sciences.

Scientists have long known from animal studies and clinical trials that use of NSAIDs, such as aspirin and ibuprofen, lowers the risk of developing intestinal polyps, which can transform into colon cancer. But they have not known why, said senior investigator Lin Zhang, Ph.D., associate professor, Department of Pharmacology and Chemical Biology, Pitt School of Medicine, and UPCI, a partner with UPMC CancerCenter.

"Our study identifies a biochemical mechanism that could explain how this preventive effect occurs," he said. "These findings could help us design new drugs to prevent colorectal cancer, which is the third leading cause of cancer-related deaths in the country."

The research team performed experiments in animal models and examined tumor samples from patients who had taken NSAIDs and those who hadn't. They found that NSAIDs activate the so-called death receptor pathway, which selectively triggers a suicide program in intestinal stem cells that have a mutation in the APC gene that renders the cells dysfunctional. Healthy cells lack the mutation, so NSAIDs cause them no harm. In that manner, the drugs instigate the early auto-destruction of cells that could lead to precancerous polyps and tumors.

"We want to use our new understanding of this mechanism as a starting point to design better drugs and effective cancer prevention strategies for those at high risk of colon cancer," Dr. Zhang said. "Ideally, we could harness the tumor-killing traits of NSAIDs and avoid possible side effects that can occur with their chronic use, such as gastrointestinal bleeding and ulcers."

Story Source:

The above story is based on materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Materials may be edited for content and length.

More:
NSAIDs prevent colon cancer by inducing death of intestinal stem cells that have mutation

Posted in Stem Cells | Comments Off on NSAIDs prevent colon cancer by inducing death of intestinal stem cells that have mutation

Biological fat with a sugar attached essential to maintaining the brain's supply of stem cells

Posted: November 3, 2014 at 6:53 pm

PUBLIC RELEASE DATE:

3-Nov-2014

Contact: Toni Baker tbaker@gru.edu 706-721-4421 Medical College of Georgia at Georgia Regents University @GRMedCenter

AUGUSTA, Ga. Fat and sugar aren't usually considered healthy staples, but scientists have found that a biological fat with a sugar attached is essential for maintaining the brain's store of stem cells.

Neural stem cells help the brain develop initially, then repopulate brain cells lost to usual cell turnover as well as to a trauma or malady, such as a head injury or stroke.

While the cell population and activity decrease as a natural part of aging, scientists at the Medical College of Georgia at Georgia Regents University are studying how neural stem cells are normally maintained with the long-term goal of helping the supply stay robust despite aging as well as infirmity.

They have discovered that in mice missing the sugar containing lipid ganglioside GD3, neural stem cells have a dramatically impaired ability to self-renew, said Dr. Robert K. Yu, MCG neuroscientist and corresponding author of the study in The Journal of Neuroscience.

The scientists focused on brain areas with typically the largest supply of neural stem cells: an area just below several midbrain cavities filled with cerebrospinal fluid, called the subventricular zone, as well as the hippocampus, a major center for learning and memory.

Mice missing ganglioside GD3 on the membranes of neural stem cells had much smaller supplies of the cells in these key areas throughout life and expressed signs of lost hope with behaviors such as not actively seeking dry land when placed in water, Yu said. Additionally, the mice had impaired maintenance of the area of the brain involved in the sense of smell as well as the portion of the hippocampus that enables formation of new memories.

The changes, which correlate with aging or illness, were corrected when GD3 was restored.

View original post here:
Biological fat with a sugar attached essential to maintaining the brain's supply of stem cells

Posted in Georgia Stem Cells | Comments Off on Biological fat with a sugar attached essential to maintaining the brain's supply of stem cells

Page 1,949«..1020..1,9481,9491,9501,951..1,9601,970..»